Kappelman MD, Adimadhyam S, Hou L, Wolfe AE, et al. Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's Disease. Am J Gastroenterol 2022 Nov 23. doi: 10.14309/ajg.0000000000002068.
PMID: 36508681